Literature DB >> 28267696

Cutaneous Radiation-associated Breast Angiosarcoma: Radicality of Surgery Impacts Survival.

George Z Li1, Mark Fairweather, Jiping Wang, Dennis P Orgill, Monica M Bertagnolli, Chandrajit P Raut.   

Abstract

OBJECTIVE: Cutaneous radiation therapy (RT)-associated breast angiosarcoma (AS) is a rare consequence of breast RT associated with poor outcomes. Previous small case series have documented high recurrence rates and poor survival. We reviewed our experience and focused on the impact of conservative versus radical resections.
METHODS: Data for patients with RT-associated breast AS evaluated at our institution from 1993 to 2015 who underwent surgery were reviewed.
RESULTS: Seventy-six women were diagnosed with RT-associated breast AS at a median 85 months from surgery for invasive breast carcinoma or ductal carcinoma in situ. Thirty-eight underwent mastectomy/wide excision with partial skin resection ("conservative") and 38 underwent resection of all or nearly all previously irradiated skin plus mastectomy ("radical"). The radical group (vs the conservative group) more often had multifocal disease (80% vs 56%, P = 0.04), chemotherapy for AS (58% vs 22%, P < 0.01), margin-negative resection (100% vs 73%, P < 0.01), reconstructive surgery (100% vs 13%, P < 0.01), and re-operation (16% vs 3%, P = 0.04). Five-year crude cumulative incidences of local recurrence and distant metastasis for radical versus conservative groups were 23% versus 76% (P < 0.01) and 18% versus 47% (P = 0.02), respectively. Five-year disease-specific survival (DSS) for radical versus conservative groups was 86% versus 46% (P < 0.01), respectively. On multivariable analysis, age, radicality of surgery, and margin were predictive of DSS.
CONCLUSIONS: For patients with RT-associated breast AS, radical resection was associated with reduced recurrence rates and improved DSS. Although margin was predictive of DSS, multifocality calls into question the reliability of negative margin assessment.

Entities:  

Mesh:

Year:  2017        PMID: 28267696     DOI: 10.1097/SLA.0000000000001753

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  10 in total

Review 1.  Angiosarcoma: a review of diagnosis and current treatment.

Authors:  Jun Cao; Jiale Wang; Chiyu He; Meiyu Fang
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

2.  Does Angiosarcoma of the Breast Need Nodal Staging?

Authors:  Joshua Herb; Ugwuji N Maduekwe; Neha Goel; Laura H Rosenberger; Philip M Spanheimer
Journal:  J Am Coll Surg       Date:  2022-05-01       Impact factor: 6.532

3.  A case of radiation-associated angiosarcoma after breast cancer.

Authors:  Nanae Horisawa; Yayoi Adachi; Masataka Sawaki; Masaya Hattori; Akiyo Yoshimura; Naomi Gondo; Haruru Kotani; Ayumi Kataoka; Kayoko Sugino; Makiko Mori; Mitsuo Terada; Yuri Ozaki; Hiroji Iwata
Journal:  Surg Case Rep       Date:  2018-11-07

4.  Doxorubicin, paclitaxel, and cisplatin based chemotherapy for the treatment of angiosarcoma: Two case reports.

Authors:  Joseph A Lewcun; Colette Pameijer; Rena Kass; Leah Cream; Diane Hershock; Ashton J Brooks; Daleela G Dodge
Journal:  Int J Surg Case Rep       Date:  2020-02-21

5.  Primary and secondary breast angiosarcoma: single center report and a meta-analysis.

Authors:  Yara Abdou; Ahmed Elkhanany; Kristopher Attwood; Wenyan Ji; Kazuaki Takabe; Mateusz Opyrchal
Journal:  Breast Cancer Res Treat       Date:  2019-09-14       Impact factor: 4.872

6.  Localized Angiosarcoma, Not One Disease: A Retrospective Single-Center Study on Prognosis Depending on the Primary Site and Etiology.

Authors:  Inna Schott; Sven-Thorsten Liffers; Farhad Farzaliyev; Johanna Falkenhorst; Hans-Ulrich Steinau; Jürgen-Walter Treckmann; Lars Erik Podleska; Christoph Pöttgen; Hans-Ulrich Schildhaus; Marit Ahrens; Uta Dirksen; Fatma-Zehra Murat; Jens T Siveke; Sebastian Bauer; Rainer Hamacher
Journal:  Sarcoma       Date:  2021-09-10

Review 7.  A Multidisciplinary Approach to Complex Dermal Sarcomas Ensures an Optimal Clinical Outcome.

Authors:  Hannah Trøstrup; Amir K Bigdeli; Christina Krogerus; Ulrich Kneser; Grethe Schmidt; Volker J Schmidt
Journal:  Cancers (Basel)       Date:  2022-03-26       Impact factor: 6.639

8.  Hyperfractionated-Accelerated Reirradiation with Proton Therapy for Radiation-Associated Breast Angiosarcoma.

Authors:  Wen Shen Looi; Julie A Bradley; Xiaoying Liang; Christiana M Shaw; Mark Leyngold; Raymond B Mailhot Vega; Eric D Brooks; Michael S Rutenberg; Lisa R Spiguel; Fantine Giap; Nancy P Mendenhall
Journal:  Int J Part Ther       Date:  2022-01-18

9.  Cutaneous Breast Radiation-associated Angiosarcoma: Anterior Chest Wall Reconstruction Options Following Extra-radical Resection.

Authors:  Juan R Mella; Kimberly M Ross; George Z Li; Bohdan Pomahac; Chandrajit P Raut; Dennis P Orgill
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-09-05

10.  Two cases of breast angiosarcoma after breast conserving surgery.

Authors:  Eriko Shiraki; Yookija Kang; Takahiro Shibayama; Shigeru Tsuyuki
Journal:  Surg Case Rep       Date:  2020-04-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.